The UK Government today pledged to fund further research into a potential drug treatment for the human form of mad cow disease, variant CJD.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Experts in the US have completed studies that suggest that quinacrine may be a potentially valuable drug in the treatment of the deadly brain wasting disease, and the Department of Health has now asked the Government-funded Medical Research Council to fast-track the design of a clinical trial into the its effectiveness.
Professor Liam Donaldson, chief medical officer, explained: “I have asked the Medical Research Council to design a trial that will evaluate the efficacy and potential side effects of the drug quinacrine so that we have this information as soon as possible.”
